Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner

Fig. 4

Exogenous administration of CXCL3 contributes to the malignant behaviors of COAD cells. (A-B) CCK-8 analysis of colon cancer cells treated with different concentrations of exogenous CXCL3. (C-D) Representative images of transwell assay for cells treated with different concentrations of exogenous CXCL3. (E-F) Transwell analysis of colon cancer cells treated with different concentrations of exogenous CXCL3. **P < 0.01 vs. 0 ng/ml

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us